ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

“Inoperable” Prostate Cancer May Be Operable, Curable

April 29, 2005

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 31, 1975

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974

In Brief: Charles Heidelberger, Sol Spiegelman Both Die of Cancer; Robert Wittes New CTEP Director

January 28, 1983

Congress Approves $4.19 Billion For NCI, $23.5 Billion For NIH, In FY2002 Appropriation.

January 4, 2002

MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues

November 29, 2013